Leadership & Staff

THE BRI EXECUTIVE COMMITTEE

The BRI is led by three rotating directors and the Senior Vice President of Research. As members of the BRI Executive Committee (EC), these representatives are responsible for directing the BRI and for representing the BWH community inside and outside the institution.

Director
Lisa Henske, MD

Co-Director
Marc Sabatine, MD

Past Director
Richard Blumberg, MD

Chief Academic Officer
Paul Anderson, MD, PhD

Executive Director
Jacqueline Slavik, PhD, MMSc

The BRI Research Oversight Committee

The BRI is governed by the Research Oversight Committee (ROC) which is made up of department representatives, BRI Center and Program Co-Chairs, and the BRI Executive Committee. The ROC was established to foster transparency and accountability in the decision-making process for the research enterprise and to plan new strategic initiatives.

HOSPITAL DEPARTMENT REPRESENTATIVES

Anesthesia
James Rathmell, MD (Chair)
Greg Crosby, MD (Alternate)

 

Dermatology
Thomas S. Kupper, MD (Chair)
Tobias Schatton, PhD, PharmD (Representative)

 

Emergency Medicine
Michael VanRooyen, MD, MPH (Chair)
Daniel Pallin, MD, MPH (Representative)

 

Medicine
Joseph Loscalzo, MD, PhD (Chair)
Nancy Berliner, MD (Representative)

 

Neurology
Martin A. Samuels, MD (Chair)
Francisco Quintana, PhD (Representative)

 

Neurosurgery
Ennio A. Chiocca, MD, PhD (Chair)
Nathalie Agar, PhD (Representative)

Newborn Medicine
Terrie E. Inder, MBCHB (Chair)
Lianne Woodward, PhD (Representative)

 

Nursing
Patricia Dykes, RN, DNSc, MA

 

Obstetrics/Gynecology
Robert Barbieri, MD (Chair)
Cynthia Morton, PhD (Representative)

 

Orthopedic Surgery
James Kang, MD (Chair)
Julie Glowacki, PhD (Alternate)

 

Pathology
Jeff Golden, MD (Chair)

Physical Medicine and Rehabilitation
Ross Zafonte, DO (Chair)

 

Psychiatry
David Silbersweig, MD (Chair)
Hadine Joffe, MD (Representative)

 

Radiation Oncology
Daphne Adele Haas-Kogan, MD (Chair)
G. Mike Makrigiorgos, PhD, DABMP/DABR (Alternate)

 

Radiology
Giles Boland, MD (Chair)
Nobuhiko Hata, PhD (Representative)

 

Surgery
Gerard Doherty, MD (Chair)
Steve Mentzer, MD (Representative)
James Lederer,  PhD (Alternate)

BRI CENTER CO-CHAIRS

Cancer Research Center
Jon Aster, MD, PhD

 

Cardiovascular, Diabetes & Metabolic Disorders Research Center
Mark Feinberg, MD
Marie McDonnell, MD
C. Keith Ozaki, MD

 

Connors-BRI Center for Research on Women’s
Health & Gender Biology
Jill Goldstein, PhD
Ursula Kaiser, MD

 

Genomics Center
Robert Green, MD, MPH
Calum MacRae, MD, PhD
Heidi Rehm, PhD
Christine Seidman, MD

Infectious and Immunologic Diseases Research Center
Ana Anderson, PhD
Rachael Clark, MD, PhD
Matthew Waldor, MD, PhD

 

Lung Research Center
Raphael Bueno, MD
Bruce Levy, MD
Edwin Kepner Silverman, MD, PhD

 

Musculoskeletal Research Center
Jeff Duryea, PhD
Nancy Ann Shadick, MD,MPH
Jessica Whited, PhD

Neurosciences Research Center
Phil DeJager, MD, PhD
Alexandra Golby, MD
Emily Stern, MD

 

Patient Centered Comparative Effectiveness Research Center
Elliot Israel, MD
Joel Weissman, PhD

 

Regenerative Medicine Research Center
Andreas Gomoll, MD
Richard T. Lee, MD

BRI PROGRAM CO-CHAIRS

Pre-Clinical Models
Daniela Dinulescu, PhD
Cynthia Lemere, PhD
Arlene Sharpe, MD, PhD

Bioinformatics
Scott Weiss, MD

Biomedical Imaging
Clare Tempany, MD

Clinical Investigation
Danny Pallin, MD, MPH
Lindsey R. Baden, MD

ELECTED REPRESENTATIVES

Junior Faculty
Carleton Eduardo Corrales, MD
Basic Research

 

Kathryn Lynn Terry, SCD
Population Science

 

SeoYoung Kim, MD, ScD, MSCE
Clinical Research 

Senior Faculty
Fred Wang, MD
Basic Research

 

J. Danny Muehlschlegel, MD
Clinical Research

 

Howard D. Sesso, SCD, MPH
Population Science

Postdoctoral Fellows

Budhaditya Banerjee, PhD
Brian Sansbury, PhD
New alternate:  Stephania Libreros Ruiz, PhD

Additional Members

President, Brigham and Women’s Hospital
Elizabeth G. Nabel, MD

 

Harvard Catalyst Representative
Elliot Antman, MD

 

Development
Susan Rapple, Chief Development Officer
Terrence McGowan, Assistant Vice President for Institutional Research
Linda Jones, Associate Vice President for Institutional Giving

 

Senior Science Communication Specialist
Haley Bridger

 

Chief Academic Officer, Partners HealthCare
Anne Klibanski, MD

 

People/Career/Development/Alumni
Thomas Michel, PhD

 

CIMIT Site Miner, BWH
Frederick Schoen, MD, PhD
Kirby Vosburgh, PhD

 

Partners Innovation
Chris Coburn
Jon Behr
Pat Fortune
Phil Licari

 

Marketing
Vicki Amalfitano

 

Partners Research Management
Andrew Chase

 

Center for Faculty Development and Diversity
Helaine Friedlander

 

Research Administration and Compliance
Allison Moriarty

 

Brigham Education Institute 
Erik K. Alexander, MD, FACP

 

BWH Translational Accelerator 
Lina Williamson, DVM PhD

 

BWH Institute for the Neurosciences
Adrian J. Ivinson, PhD

 

BWH IACUC
Srinivasan Mukundan, Jr.,MD, PhD

Scientific Advisory Board

Carole Greider, PhD
Daniel Nathans Professor & Director
Molecular Biology & Genetics
Johns Hopkins University

 

Jeff Leiden, MD, PhD
Chair, President & CEO
Vertex Pharmaceuticals

 

Terry McGuire, MBA
Co-founder & General Partner
Polaris Partners

 

Michael Rosenblatt, MD
Executive Vice President & Chief Medical Officer
Merck & Co.

 

Geoffrey W. Smith, JD
Director, Mount Sinai Institute of Technology
Professor, Department of Health Evidence and Policy Icahn School of Medicine at Mount Sinai
Managing Partner, Ascent Biomedical Ventures

The BRI Administrative Staff

JACQUELINE M. SLAVIK, PHD, MMSC
EXECUTIVE DIRECTOR, BRIGHAM RESEARCH INSTITUTE

Dr. Jacqueline M. Slavik is the executive director of the Brigham Research Institute (BRI) at Brigham and Women’s Hospital. In this role she shapes and implements the BRI’s overarching mission to accelerate discoveries that improve human health by fostering groundbreaking, interdepartmental, and interdisciplinary research, ranging from basic fundamental studies to clinical innovations.  She manages a team who works to provide a clear voice for the entire BWH research community, raise the profile of research at BWH, develop mission-centric collaborations with external entities and engage the scientific community in fundraising. Dr. Slavik received her PhD in Immunology from Harvard University, a Master of Medical Science from Harvard University and a BS in Biology from State University of New York at Albany. Dr. Slavik did her postdoctoral fellowship in the Center for Neurologic Diseases in the Department of Neurology at BWH, and held a faculty appointment as instructor in Neurology at Harvard Medical School prior to transitioning to the role of senior program manager at the BRI, from which she moved into her current leadership role. Her research interests include T lymphocytes and T lymphocyte signaling and their involvement in cancer and autoimmune diseases such as multiple sclerosis.

ANU SWAMINATHAN, PHD
DIRECTOR, SCIENTIFIC PROGRAMS & PARTNERSHIPS

Dr. Anu Swaminathan serves as the Director for Scientific Programs and Partnerships at the Brigham Research Institute (BRI). In this role, she drives a broad range of activities related to the BRI’s multiple research centers, programs and other pan-institute initiatives with the ultimate goals of increasing the visibility of the exciting research happening at BWH and catalyzing fundraising for the same in order to fuel the discovery and innovation engine of the hospital. As part of this mandate, she leads efforts to establish new research collaborations within BWH as well as with external entities including industry; diversify the funding portfolio of researchers and clinician scientists and; foster institutional involvement and community building within the hospital’s research fraternity. Anu has a PhD in Biochemistry from the University of Connecticut and brings an eclectic blend of professional experiences spanning basic research, technology commercialization, policy making and administration to her current role.

ELANA WILNER
PROGRAM COORDINATOR

Elana Wilner is the Program Coordinator at the Brigham Research Institute. Her role focuses on event logistics, pre-event communications for internal and external groups and onsite coordination for the centers and programs that make up the BRI.  Elana Graduated from University of Delaware in 2013, with a degree in Hotel, Restaurant and Institutional Management.

ALEXANDRA GALLANT
WEB MEDIA MANAGER & CREATIVE DESIGNER

Alexandra Gallant is the Web Media Manager & Creative Designer at the Brigham Research Institute. Her role is focused on identifying ways to use visual communication tools to support the efforts of the research community.  With an emphasis on user experience and design standards,  she provides creative direction for all BRI initiatives, including the development of research web sites, email communication  vehicles and print collateral.  She studied Criminal Justice and English at Northeastern University.  She is also an accomplished artist and illustrator.

Amanda Czechowski
WEB & COMMUNICATIONS COORDINATOR

Amanda Czechowski is the Web & Communications Coordinator at the Brigham Research Institute. She manages the operations for the development of new research websites for laboratories and research groups, and assists with a range of online communication efforts directed at both internal and external audiences. Amanda graduated from Bridgewater State University in 2010, with a degree in Graphic Design & Communication Studies.

SARA YOHANNES
Administrative Coordinator

Sara Yohannes is the Administrative Coordinator at the Brigham Research Institute (BRI). Sara provides administrative, financial, and event support at the BRI. As the Administrative Coordinator she is the gatekeeper of information. She came to us from the Brigham and Women’s Orthopedic and Arthritis Center in August of 2014. Sara graduated from Suffolk University with a Bachelor of Science in Business Administration in 2012.

FRANK S. DAVID, MD PHD
INNOVATION STRATEGIST

Dr. David serves as Innovation Strategist at the BRI, in addition to being Founder and Managing Director of Pharmagellan, a Boston-area biotech consulting firm.

 

After studying molecular biophysics and biochemistry at Yale, Dr. David received his M.D. and Ph.D. degrees from Columbia University’s College of Physicians and Surgeons. Dr. David completed his clinical training in anatomic pathology at Brigham and Women’s Hospital, and then served as Instructor in Pathology at Harvard Medical School and Brigham and Women’s, where he researched cell signaling in cancer and kidney development.

As Director in the consulting arm of Leerink Partners, a leading healthcare investment bank, Dr. David led advisory engagements for corporate, commercial, R&D, business development, and investor clients across all major therapeutic areas and business sectors, including biopharma, devices, diagnostics, life sciences tools, and healthcare services. He also co-founded Leerink’s Transactional Consulting practice, which advised financial and strategic investors and early-stage companies side-by-side with Leerink’s investment banking team. Dr. David also served as Director of Strategy in AstraZeneca’s Oncology Innovative Medicines unit, where he led business strategy efforts from target identification through Phase 2a, spearheaded initiatives in end-to-end franchise strategy and portfolio valuation, led external communications focused on R&D collaborators and investors, and provided commercial support to pipeline projects and in-licensing teams.

 

Dr. David writes about biomedical innovation at Forbes.com and the Pharmagellan blog, and maintains an active presence on Twitter (@Frank_S_David).

X